Franklin Resources’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$863K Buy
29,172
+409
+1% +$12.1K ﹤0.01% 2055
2025
Q1
$859K Sell
28,763
-1,717
-6% -$51.3K ﹤0.01% 2021
2024
Q4
$873K Sell
30,480
-145
-0.5% -$4.15K ﹤0.01% 2035
2024
Q3
$1.16M Buy
30,625
+3,620
+13% +$138K ﹤0.01% 1919
2024
Q2
$870K Buy
27,005
+1,998
+8% +$64.3K ﹤0.01% 1983
2024
Q1
$971K Buy
25,007
+629
+3% +$24.4K ﹤0.01% 1961
2023
Q4
$750K Buy
24,378
+1,577
+7% +$48.5K ﹤0.01% 1761
2023
Q3
$510K Buy
22,801
+4,357
+24% +$97.4K ﹤0.01% 1896
2023
Q2
$396K Buy
+18,444
New +$396K ﹤0.01% 2071
2021
Q1
Sell
-1,255,371
Closed -$25.1M 1984
2020
Q4
$25.1M Sell
1,255,371
-410,501
-25% -$8.22M 0.01% 769
2020
Q3
$34.7M Buy
1,665,872
+1,209
+0.1% +$25.2K 0.02% 644
2020
Q2
$29.1M Sell
1,664,663
-165,109
-9% -$2.89M 0.02% 650
2020
Q1
$29.9M Buy
1,829,772
+59,620
+3% +$974K 0.02% 582
2019
Q4
$36.4M Sell
1,770,152
-92,819
-5% -$1.91M 0.02% 614
2019
Q3
$21.4M Buy
1,862,971
+7,126
+0.4% +$81.8K 0.01% 730
2019
Q2
$24.4M Buy
1,855,845
+22,007
+1% +$289K 0.01% 706
2019
Q1
$27.8M Sell
1,833,838
-451
-0% -$6.83K 0.01% 666
2018
Q4
$31.5M Buy
1,834,289
+74,783
+4% +$1.28M 0.02% 590
2018
Q3
$25.9M Buy
1,759,506
+347,064
+25% +$5.12M 0.01% 704
2018
Q2
$33.7M Sell
1,412,442
-56,677
-4% -$1.35M 0.02% 632
2018
Q1
$37.5M Sell
1,469,119
-42,656
-3% -$1.09M 0.02% 608
2017
Q4
$27.9M Sell
1,511,775
-721,372
-32% -$13.3M 0.01% 711
2017
Q3
$23.4M Buy
2,233,147
+29,366
+1% +$308K 0.01% 752
2017
Q2
$27.6M Sell
2,203,781
-27,422
-1% -$343K 0.01% 705
2017
Q1
$22.4M Buy
2,231,203
+433,301
+24% +$4.36M 0.01% 755
2016
Q4
$28M Buy
1,797,902
+890,868
+98% +$13.9M 0.01% 698
2016
Q3
$17.5M Buy
907,034
+3,432
+0.4% +$66.1K 0.01% 846
2016
Q2
$10.7M Buy
903,602
+74,003
+9% +$877K 0.01% 952
2016
Q1
$15.1M Buy
829,599
+505,299
+156% +$9.17M 0.01% 866
2015
Q4
$8.92M Sell
324,300
-11,000
-3% -$303K ﹤0.01% 1030
2015
Q3
$7.41M Buy
335,300
+4,700
+1% +$104K ﹤0.01% 1071
2015
Q2
$5.9M Buy
+330,600
New +$5.9M ﹤0.01% 1150